Evidence map›Paper›PMID 42500821›Full record

ArticleNucleic acids research2026

Molecular basis of UV lesion binding and repair inhibition by ETS-family transcription factors.

Smitha Sivapragasam, James Ross Terrell, Arjan van der Vaart, Markus W Germann, Marian F Laughery, Michaela E Everly, Shiva P Adhikari, Patrick J Hrdlicka, John J Wyrick, Gregory M K Poon

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Smitha SivapragasamSchool of Molecular Biosciences, Washington State University, Pullman WA 99164,USA.ORCID 0000-0002-5599-9988
James Ross TerrellDepartment of Chemistry, Georgia State University, Atlanta, GA 30303,USA.ORCID 0000-0001-5394-5663
Arjan van der VaartDepartment of Chemistry, University of South Florida, Tampa, FL 33620,USA.ORCID 0000-0002-8950-1850
Markus W GermannDepartment of Chemistry, Georgia State University, Atlanta, GA 30303,USA.
Marian F LaugherySchool of Molecular Biosciences, Washington State University, Pullman WA 99164,USA.
Michaela E EverlyDepartment of Chemistry, University of Idaho, Moscow, ID 83844,USA.
Shiva P AdhikariDepartment of Chemistry, University of Idaho, Moscow, ID 83844,USA.
Patrick J HrdlickaDepartment of Chemistry, University of Idaho, Moscow, ID 83844,USA.ORCID 0000-0002-8113-0450
John J WyrickSchool of Molecular Biosciences, Washington State University, Pullman WA 99164,USA.ORCID 0000-0002-7911-3803
Gregory M K PoonDepartment of Chemistry, Georgia State University, Atlanta, GA 30303,USA.ORCID 0000-0001-5107-9458

Funding

Genome-wide analysis of the formation and mutagenesis of atypical UV photoproducts in skin cancerR01ES032814 · NIEHS · WASHINGTON STATE UNIVERSITY · PI STEVEN A ROBERTS, John J Wyrick · 2021 to 2026
$5.8M
Regulation of DNA Excision Repair in ChromatinR01ES028698 · NIEHS · WASHINGTON STATE UNIVERSITY · PI John J Wyrick · 2018 to 2026
$2.7M
Direct chemical control of the hematopoietic master transcription factor PU.1R01HL155178 · NHLBI · GEORGIA STATE UNIVERSITY · PI POON, GREGORY MAN KAI · 2021 to 2023
$1.2M
Identifying recurrent driver mutations in skin cancers by targeted UV damage sequencingR21ES035139 · NIEHS · WASHINGTON STATE UNIVERSITY · PI WYRICK, JOHN J · 2023 to 2024
$449k
The role of Elf1 in transcription coupled-nucleotide excision repairR21ES035888 · NIEHS · WASHINGTON STATE UNIVERSITY · PI SELVAM, KATHIRESAN, WYRICK, JOHN J · 2024 to 2025
$438k
Profiling the specificity of SPI1 and SPIB activity for drug discoveryR03TR004842 · NCATS · GEORGIA STATE UNIVERSITY · PI POON, GREGORY MAN KAI · 2025 to 2025
$156k
National Science Foundation MCB 2028902NCATS NIH HHS R03 TR004842NHLBI NIH HHS R01 HL155178NIEHS NIH HHS R01 ES028698NIEHS NIH HHS R01 ES032814NIEHS NIH HHS R21 ES035139NIEHS NIH HHS R21 ES035888NIH HHS ES028698NIH HHS ES032814NIH HHS ES035139NIH HHS ES035888NIH HHS HL155178NIH HHS TR004842
6 · The paper itself

Abstract

Mutation hotspots in melanoma frequently occur at DNA binding sites of E26 transformation-specific (ETS)-family transcription factors, as ETS factors stimulate the formation of UV-induced cyclobutane pyrimidine dimers (CPDs) while suppressing repair at ETS-bound DNA sites. To elucidate the molecular mechanism by which ETS factors bind to damaged DNA sites and inhibit repair, we investigated the binding of members from the three major classes of the ETS superfamily (Ets1, ELF1, and PU.1) to cognate DNA containing a cis-syn TpT CPD. These site-specific CPDs modulated ETS recognition and repair by a model repair enzyme in a position-dependent manner. Specifically, a deaminated CPD located in a damage hotspot in the ETS binding motif consistently stimulated binding and inhibited T4 PDG (a CPD repair enzyme) by all three paralogs. Co-crystal structures of PU.1 reveal that CPDs and mismatches are recognized within the framework of canonical ETS/DNA complexes. Molecular dynamics simulations in explicit solvent show that CPD introduces compensatory structural dynamics to both the free and ETS-bound states that strongly modify the underlying thermodynamics of recognition. The results offer a molecular basis for how ETS factors induce mutation hotspots in skin cancers and other UV-exposed tissues by binding to CPD-containing sites and inhibiting their repair.

Indexed as

DNA RepairProto-Oncogene Proteins c-etsPyrimidine DimersUltraviolet RaysBinding SitesDNADNA DamageExcision RepairHumansMolecular Dynamics SimulationProtein BindingProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-ActivatorsDNAProto-Oncogene ProteinsProto-Oncogene Proteins c-etsProto-Oncogene Protein Spi-1Pyrimidine DimersTrans-Activators

Identifiers

PMID42500821
PMCPMC13401050

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.